Does uremia cause vascular dysfunction?

Kidney and Blood Pressure Research

Volumn 34, Issue 4, 2011, Pages 284-290

  Brunet, Philippe ^a,b   Gondouin, Bertrand ^a,b   Duval Sabatier, Ariane ^a,b   Dou, Laetitia ^a   Cerini, Claire ^a   Dignat George, Françoise ^a   Jourde Chiche, Noémie ^b   Argiles, Angel ^c   Burtey, Stéphane ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Arteriosclerosis; Atherosclerosis; Chronic kidney disease; Uremic toxins; Vascular disease

Indexed keywords

4 CRESYL SULFATE; ADVANCED GLYCATION END PRODUCT; BETA 2 MICROGLOBULIN; CELL ADHESION MOLECULE; DIADENOSINE POLYPHOSPHATE; GUANIDINE DERIVATIVE; INDICAN; INDOLEACETIC ACID; LEPTIN; MATRIX METALLOPROTEINASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PHOSPHATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; THROMBOMODULIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UREMIC TOXIN; VON WILLEBRAND FACTOR;

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LEUKOCYTE ACTIVATION; MORTALITY; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE PRESSURE; RESTENOSIS; SMOOTH MUSCLE FIBER; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UREMIA; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

HUMANS; MUSCLE, SMOOTH, VASCULAR; UREMIA; VASCULAR CALCIFICATION; VASCULAR DISEASES;

EID: 79959532685     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000327131     Document Type: Conference Paper

References (69)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in pro-longed maintenance hemodialysis. N Engl J Med 1974; 290:697-701.
2. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15:218-223. (Pubitemid 30064276)
3. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyo-hara Y, Sueishi K: Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japa-nese elders: the Hisayama study. Am J Kidney Dis 2010; 55:21-30.
4. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Ad-vanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106:100-105. (Pubitemid 34747448)
5. Bro S, Bentzon JF, Falk E, Andersen CB, Ol-gaard K, Nielsen LB: Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 2003; 14: 2466-2474. (Pubitemid 37169332)
6. Buzello M, Törnig J, Faulhaber J, Ehmke H, Ritz E, Amann K: The apolipoprotein e knockout mouse: a model documenting ac-celerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14: 311-316. (Pubitemid 36150854)
7. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109-116. (Pubitemid 43073162)
8. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
9. Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, Van-holder RC: In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004; 65:2184-2192. (Pubitemid 38670004)
10. Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Co-hen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R, European Ure-mic Toxin Work Group (EUTox): Guanidino compounds as cause of cardiovascular dam-age in chronic kidney disease: an in vitro evaluation. Blood Purif 2010; 30:277-287.
11. Hou FF, Ren H, Owen WF Jr, Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X: En-hanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol 2004; 15: 1889-1896. (Pubitemid 38822069)
12. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R: P-cresylsul-phate, the main in vivo metabolite of p-cre-sol, activates leucocyte free radical produc-tion. Nephrol Dial Transplant 2007; 22: 592-596. (Pubitemid 46189906)
13. Masai N, Tatebe J, Yoshino G, Morita T: In-doxyl sulfate stimulates monocyte chemoat-tractant protein-1 expression in human um-bilical vein endothelial cells by inducing ox-idative stress through activation of the NADPH oxidase-nuclear factor-κB pathway Circ J 2010; 74:2216-2224.
14. Ito S, Osaka M, Higuchi Y, Nishijima F, Ishii H, Yoshida M: Indoxyl sulfate induces leuko-cyte-endothelial interactions through up-regulation of E-selectin. J Biol Chem 2010; 285:38869-38875.
15. Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T: Indoxyl sulfate upregulates ex-pression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol 2010; 31:435-441.
16. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P: The uremic solute indoxyl sulfate induces oxida-tive stress in endothelial cells. J Thromb Haemost 2007; 5: 1302-1308. (Pubitemid 46902134)
17. Rojas A, Romay S, González D, Herrera B, Delgado R, Otero K: Regulation of endothe-lial nitric oxide synthase expression by albu-min-derived advanced glycosylation end products. Circ Res 2000; 86:E50-E54.
18. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: En-hanced cellular oxidant stress by the interac-tion of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269: 9889-9897. (Pubitemid 24196599)
19. Jankowski J, Hagemann J, Yoon MS, van der Giet M, Stephan N, Zidek W, Schluter H, Te-pel M: Increased vascular growth in hemo-dialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int 2001; 59: 1134-1141. (Pubitemid 32206878)
20. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD: Impaired renal function is associated with markers of endothelial dysfunction and Increased inflammatory activity. Nephrol Dial Transplant 2003; 18: 892-898. (Pubitemid 36592529)
21. Chung AW, Yang HH, Kim JM, Sigrist MK, Chum E, Gourlay WA, Levin A: Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 2009; 120: 792-801.
22. Coll B, Rodríguez JA, Craver L, Orbe J, Mar-tínez-Alonso M, Ortiz A, Díez J, Beloqui O, Borras M, Valdivielso JM, Fernández E, Páramo JA: Serum levels of matrix metallo-proteinase-10 are associated with the sever-ity of atherosclerosis in patients with Chronic kidney disease. Kidney Int 2010; 78:1275-1280.
23. Passauer J, Bussemaker E, Range U, Plug M, Gross P: Evidence in vivo showing increase of baseline nitric oxide generation and im-pairment of endothelium-dependent vaso-dilation in normotensive patients on chronic hemodialysis. J Am Soc Nephrol 2000; 11: 1726-1734.
24. Vanhoutte PM, Feletou M, Taddei S: Endo-thelium-dependent contractions in Hypertension. Br J Pharmacol 2005; 144: 449-458.
25. Zieman SJ, Melenovsky V, Kass DA: Mecha-nisms, pathophysiology, and therapy of arte-rial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943. (Pubitemid 40627836)
26. Fliser D, Kielstein JT, Haller H, Bode-Böger SM: Asymmetric dimethylarginine: a car-diovascular risk factor in renal disease? Kidney Int Suppl 2003; 84:S37-S40. (Pubitemid 36513371)
27. Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, Ter Wee PM, van Guldener C: Plasma asym-metric dimethylarginine (ADMA) concen-tration is independently associated with ca-rotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int 2005; 68: 2230-2236. (Pubitemid 43117798)
28. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-3388. (Pubitemid 46179341)
29. Faure V Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: El-evation of circulating endothelial micropar-ticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
30. Meijers BK, Van Kerckhoven S, Verbeke K Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54:891-901.
31. London GM, Guerin AP: Influence of arte-rial pulse and reflected waves on blood pres-sure and cardiac function. Am Heart J 1999; 138: 220-224.
32. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal dis-ease. Circulation 1999; 99: 2434-2439. (Pubitemid 29218240)
33. Silberberg JS, Barre PE, Prichard SS, Snider-man AD: Impact of left ventricular hypertro-phy on survival in end-stage renal disease. Kidney Int 1989; 36:286-290. (Pubitemid 19202488)
34. Iseki K Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, Sunagawa H, Yo-shihara K Yoshi S, Toma S, Kowatari T, Wake T, Oura T, Fukiyama K: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997; 51: 1212-1217. (Pubitemid 27186548)
35. Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 1984; 25:653-659. (Pubitemid 14079960)
36. Kopeć G, Podolec P, Podolec J, Rubiś P, Zmudka K, Tracz W: Atherosclerosis pro-gression affects the relationship between en-dothelial function and aortic stiffness. Ath-erosclerosis 2009; 204:250-254.
37. Dursun I, Poyrazoglu HM, Gunduz Z, Ulger H, Yykylmaz A, Dusunsel R, Patyroglu T, Gurgoze M: The relationship between circu-lating endothelial microparticles and arte-rial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 2009; 24:2511-2518.
38. Miyata T, van Ypersele de Strihou C, Kuro-kawa K Baynes JW: Alterations in nonenzy-matic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999; 55: 389-399. (Pubitemid 29082866)
39. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JW, Lafeber FP, Baynes JW, TeKoppele JM: Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000; 275:39027-39031. (Pubitemid 32058915)
40. Konova E, Baydanoff S, Atanasova M, Vel-kova A: Age-related changes in the glycation of human aortic elastin. Exp Gerontol 2004; 39:249-254. (Pubitemid 38169417)
41. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam com-puted tomography in the evaluation of car-diac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401. (Pubitemid 26075849)
42. O'Neill WC, Lomashvili KA: Recent prog-ress in the treatment of vascular calcifica-tion. Kidney Int 2010; 78:1232-1239.
43. Huang PH, Chen LC, Leu HB, Ding PY, Chen JW, Wu TC, Lin SJ: Enhanced coronary cal-cification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest 2005; 128: 810-815.
44. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA: Association of pulse wave velocity with vascular and valvular cal-cification in hemodialysis patients. Kidney Int 2007; 71: 802-807. (Pubitemid 46624028)
45. London GM, Guérin AP, Marchais SJ, Mé-tivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: im-pact on all-cause and cardiovascular mortal-ity. Nephrol Dial Transplant. 2003; 18: 1731-1740. (Pubitemid 37098542)
46. Moe SM, Chen NX: Pathophysiology of vas-cular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567. (Pubitemid 39274370)
47. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731. (Pubitemid 35286280)
48. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX: Uremia induces the osteoblast dif-ferentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63:1003-1011. (Pubitemid 36315578)
49. Mizobuchi M, Towler D, Slatopolsky E: Vas-cular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009; 20:1453-1464.
50. Mozar A, Haren N, Chasseraud M, Louvet L, Mazière C, Wattel A, Mentaverri R, Morlière P, Kamel S, Brazier M, Mazière JC, Massy ZA: High extracellular inorganic phosphate concentration inhibits RANK-RANKL sig-naling in osteoclast-like cells. J Cell Physiol 2008; 215:47-54. (Pubitemid 351363190)
51. Huang PH, Chen LC, Leu HB, Ding PY, Chen JW, Wu TC, Lin SJ: Enhanced coronary cal-cification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest 2005; 128: 810-815.
52. Poggio P, Grau JB, Field BC, Sainger R, See-fried WF, Rizzolio F, Ferrari G: Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and con-trols. J Cell Physiol 2010, E-pub ahead of print.
53. Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 2009; 16: 329-338.
54. Tsai S, Butler J, Rafii S, Liu B, Kent KC: The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg 2009; 49: 502-510.
55. Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu CM, Yeh HI, Lan YJ, Yeh CH, Stanford WL: Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesen-chymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 2008; 28:54-60.
56. Ota T, Umeda H, Yokota S, Miyata S, Taka-mura A, Sugino S, Hayashi K, Ishiki R Takeichi Y, Iwase M, Inagaki H, Murohara T: Relationship between severity of renal im-pairment and 2-year outcomes after sirolim-us-eluting stent implantation. Am Heart J 2009; 158:92-98.
57. Dou L, Bertrand E, Cerini C, Faure V, Sam-pol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451. (Pubitemid 38130638)
58. Herbrig K, Pistrosch F, Oelschlaegel U, Wichmann G, Wagner A, Foerster S, Richter S, Gross P, Passauer J: Increased total num-ber but impaired migratory activity and ad-hesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849. (Pubitemid 39445916)
59. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D: Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66:641-646. (Pubitemid 38982006)
60. Jourde-Chiche N, Dou L, Sabatier F, Calaf R Cerini C, Robert S, Camoin-Jau L, Charpiot P, Argiles A, Dignat-George F, Brunet P: Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular in-jury in hemodialysis patients. J Thromb Haemost 2009; 7:1576-1584.
61. Chan CT, Li SH, Verma S: Nocturnal hemo-dialysis is associated with restoration of Impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005; 289:F679-F684. (Pubitemid 41324188)
62. Chan CT, Mardirossian S, Faratro R, Rich-ardson RM: Improvement in lower-extremi-ty peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 2003; 41:225-229. (Pubitemid 36043371)
63. Langer S, Kokozidou M, Heiss C, Kranz J, Kessler T, Paulus N, Krüger T, Jacobs MJ, Lente C, Koeppel TA: Chronic kidney dis-ease aggravates arteriovenous fistula dam-age in rats. Kidney Int 2010; 78:1312-1321.
64. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl3):S112-S119. (Pubitemid 28527268)
65. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N, European Uremic Toxin Work Group: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056. (Pubitemid 40862092)
66. Chronic Kidney Disease Prognosis Consor-tium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of es-timated glomerular filtration rate and albu-minuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
67. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Van-holder R, Massy ZA, European Uremic Tox-in Work Group (EUTox): Serum indoxyl sul-fate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558.
68. Meijers BK, Bammens B, De Moor B, Ver-beke K, Vanrenterghem Y, Evenepoel P: Free pcresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180. (Pubitemid 351620433)
69. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Chouk-roun G, Vanholder R, Massy ZA, European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic Kidney disease. Nephrol Dial Transplant 2010; 25:1183-1191.